FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4360614741> ?p ?o ?g. }

• W4360614741 abstract "<h3>Background and Importance</h3> Paediatric population are predisposed to have more adverse drug reactions (ADR) and other drug related problems (DRP). Social media (SM) could be an innocuous source of pharmacovigilance. <h3>Aim and Objectives</h3> Assess ADR and DRP evidence reported in SM. <h3>Material and Methods</h3> A systematic review according PRISMA recommendations was conducted in MEDLINE, Embase and LILACS. Articles in English, Spanish and Catalan languages from inception up to September 2021 were reviewed using search terms related to paediatric age, SM and DRP. In the screening phase, articles not mentioning paediatrics and SM were excluded including grey literature. In the eligibility phase, articles related to non-pharmacological treatments/substances, surveys, recruitment protocols, sociological studies, professional use of SM and technological implementation were excluded. Articles including information about commonly used drugs in paediatrics were evaluated.Demographic variables, SM platforms, medicines and type of information (ADR, DRP or experiences and opinions (EO)) were analysed. <h3>Results</h3> 6079 articles were assessed and 28 (0,4%) met the inclusion criteria. 16 (57%) studies werequalitative, 6 (21%) quantitative and qualitative and quantitative 6 (21%). When mentioned, most articles analysed data from parents/caregivers (10;36%) and adolescents (2;7%). Gender of SM userwas not systematically reported but females were reported in 7 (25%) articles in a range in of 22-77%, in an article 245 females compared to 74 males and one referred that posts were mostly from mothers of young children. Most articles included data from forums (13;46%), Twitter (5;18%) and Facebook (6;21%). 17 (61%) reported information about vaccines, 3 (11%) asthma medications and 8 (28%) other medicines.8 articles (28%) reported an ADR including tremor, auto-injector wounds and vaccine ADR. Only in one article the severity was reported. EO were reported in 25 (89%) studies and 10 (36%) articles mentioned a DRP. Studies reported lack of adherence (4;14%), difficulties (3;11%) or doubts (2;7%) about drug administration of asthma inhalers (2;7%), epinephrine auto-injector (1;4%), antibiotics (1;4%), oral drugs (1;4%), ophthalmic drugs (1;4%) and topical drugs (1;4%). <h3>Conclusion and Relevance</h3> Articles evaluating pharmacological drugs in paediatrics focused mostly on EO and scarce data about ADR and DRP were mentioned in SM. Consequently, more studies are required to take advantage from SM as a potential tool in paediatric pharmacovigilance. <h3>References and/or Acknowledgements</h3> <h3>Conflict of Interest</h3> No conflict of interest" @default.
• W4360614741 created "2023-03-24" @default.
• W4360614741 creator A5005824864 @default.
• W4360614741 creator A5011486635 @default.
• W4360614741 creator A5011670429 @default.
• W4360614741 creator A5023903024 @default.
• W4360614741 creator A5030714480 @default.
• W4360614741 creator A5042826543 @default.
• W4360614741 creator A5053602450 @default.
• W4360614741 creator A5078200329 @default.
• W4360614741 creator A5080758634 @default.
• W4360614741 creator A5087239671 @default.
• W4360614741 date "2023-03-01" @default.
• W4360614741 modified "2023-10-14" @default.
• W4360614741 title "5PSQ-100 Utility of social media as a source of paediatric drug safety, a systematic review" @default.
• W4360614741 doi "https://doi.org/10.1136/ejhpharm-2023-eahp.303" @default.
• W4360614741 hasPublicationYear "2023" @default.
• W4360614741 type Work @default.
• W4360614741 citedByCount "0" @default.
• W4360614741 crossrefType "proceedings-article" @default.
• W4360614741 hasAuthorship W4360614741A5005824864 @default.
• W4360614741 hasAuthorship W4360614741A5011486635 @default.
• W4360614741 hasAuthorship W4360614741A5011670429 @default.
• W4360614741 hasAuthorship W4360614741A5023903024 @default.
• W4360614741 hasAuthorship W4360614741A5030714480 @default.
• W4360614741 hasAuthorship W4360614741A5042826543 @default.
• W4360614741 hasAuthorship W4360614741A5053602450 @default.
• W4360614741 hasAuthorship W4360614741A5078200329 @default.
• W4360614741 hasAuthorship W4360614741A5080758634 @default.
• W4360614741 hasAuthorship W4360614741A5087239671 @default.
• W4360614741 hasBestOaLocation W43606147411 @default.
• W4360614741 hasConcept C109359841 @default.
• W4360614741 hasConcept C136764020 @default.
• W4360614741 hasConcept C138885662 @default.
• W4360614741 hasConcept C15708023 @default.
• W4360614741 hasConcept C15744967 @default.
• W4360614741 hasConcept C164105321 @default.
• W4360614741 hasConcept C17744445 @default.
• W4360614741 hasConcept C187212893 @default.
• W4360614741 hasConcept C189708586 @default.
• W4360614741 hasConcept C199539241 @default.
• W4360614741 hasConcept C2779473830 @default.
• W4360614741 hasConcept C2780035454 @default.
• W4360614741 hasConcept C2908647359 @default.
• W4360614741 hasConcept C41008148 @default.
• W4360614741 hasConcept C512399662 @default.
• W4360614741 hasConcept C518677369 @default.
• W4360614741 hasConcept C57658597 @default.
• W4360614741 hasConcept C61904560 @default.
• W4360614741 hasConcept C71924100 @default.
• W4360614741 hasConcept C77805123 @default.
• W4360614741 hasConcept C98274493 @default.
• W4360614741 hasConcept C99454951 @default.
• W4360614741 hasConceptScore W4360614741C109359841 @default.
• W4360614741 hasConceptScore W4360614741C136764020 @default.
• W4360614741 hasConceptScore W4360614741C138885662 @default.
• W4360614741 hasConceptScore W4360614741C15708023 @default.
• W4360614741 hasConceptScore W4360614741C15744967 @default.
• W4360614741 hasConceptScore W4360614741C164105321 @default.
• W4360614741 hasConceptScore W4360614741C17744445 @default.
• W4360614741 hasConceptScore W4360614741C187212893 @default.
• W4360614741 hasConceptScore W4360614741C189708586 @default.
• W4360614741 hasConceptScore W4360614741C199539241 @default.
• W4360614741 hasConceptScore W4360614741C2779473830 @default.
• W4360614741 hasConceptScore W4360614741C2780035454 @default.
• W4360614741 hasConceptScore W4360614741C2908647359 @default.
• W4360614741 hasConceptScore W4360614741C41008148 @default.
• W4360614741 hasConceptScore W4360614741C512399662 @default.
• W4360614741 hasConceptScore W4360614741C518677369 @default.
• W4360614741 hasConceptScore W4360614741C57658597 @default.
• W4360614741 hasConceptScore W4360614741C61904560 @default.
• W4360614741 hasConceptScore W4360614741C71924100 @default.
• W4360614741 hasConceptScore W4360614741C77805123 @default.
• W4360614741 hasConceptScore W4360614741C98274493 @default.
• W4360614741 hasConceptScore W4360614741C99454951 @default.
• W4360614741 hasLocation W43606147411 @default.
• W4360614741 hasOpenAccess W4360614741 @default.
• W4360614741 hasPrimaryLocation W43606147411 @default.
• W4360614741 hasRelatedWork W2320835815 @default.
• W4360614741 hasRelatedWork W2590526179 @default.
• W4360614741 hasRelatedWork W2745152136 @default.
• W4360614741 hasRelatedWork W2806782888 @default.
• W4360614741 hasRelatedWork W2907833630 @default.
• W4360614741 hasRelatedWork W3118927879 @default.
• W4360614741 hasRelatedWork W3176106399 @default.
• W4360614741 hasRelatedWork W3209452452 @default.
• W4360614741 hasRelatedWork W4255514511 @default.
• W4360614741 hasRelatedWork W4281550516 @default.
• W4360614741 isParatext "false" @default.
• W4360614741 isRetracted "false" @default.
• W4360614741 workType "article" @default.